Fig. 1From: Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experiencea Kaplan-Meier curves on progression-free survival (PFS) and (b) overall survival (OS) for patients (n = 11) who were treated with the R-T regimenBack to article page